CLIENT PORTAL LOGIN:
Life Sciences
-
The life sciences industry has a rich history of dynamic transformation. Most recently, research and discovery collaborations and merger and acquisition deals have become increasingly prevalent even as new innovations blur the lines between therapeutics, devices, diagnostics and healthcare IT. The core mission to improve human life through scientific advancement remains, but escalating costs and changing government policy require new strategies, business and funding models for success in the sector. The next generation of leaders in life sciences organizations must be prepared to adapt, deliver value and grow companies that solve not only scientific, but also regulatory and reimbursement challenges in an increasingly competitive environment.
AMAG Pharmaceuticals
Placements
- Executive Director, Business Development
Aldeyra
Placements
Alnylam
Placements
- Vice President, Manufacturing
- Vice President, Quality Assurance
Apple Tree Partners
Placements
- Associate Entrepreneur in Residence
- Genomic Informatics Partner, Healthcare Services
Biogen
Placements
Senior Vice President, Public Affairs Vice President, Marketing
Cell Signaling Technology
Placements
Cognoa
Placements
- Chief Executive Officer
Conformis
Placements
- Senior Vice President, Operations
Deciphera
Placements
HIG BioVentures
Placements
- Investment Professionals
Histogenics
Placements
- President and Chief Executive Officer
Incline Therapeutics
Placements
- Chief Commercial Officer
Ironwood Pharmaceuticals
Placements
- Vice President, Communications
Jennerex Biotherapeutics
Placements
- Chief Executive Officer
NanoString
Placements
- Vice President, Global Sales
Novartis
Placements
- Chief Business and Financial Officer, Viamet Pharmaceuticals
- Senior Vice President, Business Development, Akebia Therapeutics
- Senior Vice President, Research and Early Development, Aileron Therapeutics
Osage Partners
Placements
Oxford Immunotec
Placements
- Chief Financial Officer
- General Manager
- Vice President, Marketing
- Vice President, Sales
Poxel
Placements
Puma Biotechnology
Placements
- Senior Vice President, Clinical Research and Development
QSpex
Placements
- Chief Executive Officer
RF Surgical Systems
Placements
- President and Chief Executive Officer
Rexahn
Placements
President and Chief Executive Officer
Sarepta Therapeutics
Placements
- Vice President, Global Regulatory Affairs
Satellite Healthcare
Placements
- Independent Director
Somnomed
Placements
- Chief Medical Officer
- President, North America
- Vice President, Managed Care
Synthetic Genomics
Placements
- Vice President, Operations
Theravance
Placements
- Vice President, Clinical Development
- Vice President, Drug Metabolism and Pharmacokinetics
Thrasos Therapeutics
Placements
- Chief Medical Officer
Thrombogenics NV
Placements
- Board Member
Trius Therapeutics
Placements
- Chief Commercial Officer
-
PRACTICE OVERVIEW
The members of our life sciences practice are trusted advisors to boards, investors, and executive teams on their most critical recruitments and organizational needs. We bring to bear deep industry expertise, a rigorous and transparent search process, and intellectually honest candidate assessments. We take the time to know our clients and their exact organizational need and then leverage our network, dedicated research function and robust candidate development to provide customized and meaningful solutions to our searches. Our consultants serve every segment of the life sciences industry: biotechnology, pharmaceuticals, medical devices, diagnostics, tools and instruments, healthcare IT, and agribiotechnology. We recruit for functional roles at the senior-most level, including: board members, general management, commercial, corporate and business development, research and development, operations, finance, and human resources, among others.
-
Lead Consultants
- NEWS
- November 6 2017 - Melinta Therapeutics Announces Successful Completion of Merger
- October 31 2017 - Melinta and Cempra Name Industry Leader Daniel Wechsler as President and Chief Executive Officer of
- July 24 2017 - Oxford Immunotec Appoints Richard Wenstrup, MD, as Chief Medical Officer
- June 14 2017 - Cognoa Hires Vice President of Medical, Further Advancing Developmental Diagnosis Technology
- June 5 2017 - Histogenics Corporation Announces the Appointment of Donald Haut, Ph.D. as Chief Business Officer
- May 23 2017 - Zymergen Enhances R&D Leadership with Key Hires
- April 20 2017 - Continuous positive compensation trends indicate a healthy private life sciences sector
- April 6 2017 - Ironwood Pharmaceuticals Appoints Dr. Christopher Wright as Senior Vice President of Global Developm
- March 24 2017 - Merck & Co. Appoints Dean Y. Li, M.D., Ph.D. as Vice President, Head of Translational Medicine
- January 10 2017 - An Open Letter to the BioPharma Community
- January 9 2017 - Medical Technology: What Changing Venture Capital Investments Signal
- November 10 2016 - WAVE Life Sciences Appoints Christian Henry to its Board of Directors
- November 7 2016 - CeQur® Appoints Robert Farra Chief Executive Officer
- October 28 2016 - Alzheimer’s Drug Development Company Cognition Therapeutics Appoints Kenneth I. Moch President & CEO
- October 17 2016 - Michael Aldridge Joins Codexis as Senior Vice President, Corporate & Strategic Development
- September 29 2016 - Epizyme Appoints Pamela Strode as Vice President, Regulatory Affairs and Quality Assurance
- August 17 2016 - WAVE Life Sciences Appoints Keith Regnante as Chief Financial Officer
- August 8 2016 - ReShape Medical® Announces the Appointment of Michael J. Mangano as President and Chief Executive Of
- August 8 2016 - Cardiome Announces the Addition of Two Key Members to its Management Team
- August 2 2016 - Paul Bolno, CEO at WAVE and current Park Square client, has been named to PharmaVoice 100
- May 2 2016 - Novo Nordisk Appoints Aaron Schwartz as Director, R&D Sourcing
- April 11 2016 - Deciphera Pharmaceuticals Appoints David Brooks, M.D., Ph.D. as Vice President, Clinical Development
- April 7 2016 - Alice Li will direct Cornell’s technology transfer group
- April 5 2016 - FLX Bio Completes Leadership Team in Immuno-Oncology Drug Discovery
- March 14 2016 - Poxel Appoints Jonae R. Barnes as Senior Vice President Investor Relations and Public Relations, bas
- March 7 2016 - Nanotechnology expert selected to lead OHSU’s large-scale early cancer detection initiative
- March 3 2016 - Mathai Mammen, The Anti-Shkreli, Brings Heart And A Touch Of Vagelos To Merck R&D
- January 25 2016 - Theravance Biopharma Appoints Richard Graham as Senior Director, Clinical Pharmacology
- January 11 2016 - Aldeyra Therapeutics Appoints David J. Clark, M.D. as Chief Medical Officer
- December 4 2015 - For Epizyme chief executive, the work is personal
- November 19 2015 - Cognoa Promises Worried Parents Faster Answers
- November 3 2015 - Castle Biosciences Announces the Appointment of Federico Monzon, M.D., FCAP as Chief Medical Officer
- July 26 2015 - UMass Medical School seeks to bolster profits from science
- July 13 2015 - Oregon Health & Science University (OHSU) Appoints Brendan Rauw as Vice President, Technology Transf
- June 22 2015 - Histogenics Corporation Announces Appointment of New Chief Financial Officer
- June 1 2015 - Theravance Biopharma Appoints Gary Barrera as Head, Quality
- June 1 2015 - Cell Signaling Technology Appoints Kazuyuki Kiyota as Representative Director and President, Cell Si
- March 23 2015 - TransMedics Appoints Stephen Gordon as Chief Financial Officer
- March 17 2015 - Oxford Immunotec Appoints Stephen M. Gansler as Senior Vice President and Global Head of Human Resou
- February 4 2015 - Rexahn Pharmaceuticals Announces the Appointment of Ely Benaim, M.D., as Chief Medical Officer
- January 5 2015 - Element Science, Inc. Appoints Christopher Hasser as Vice President, Research and Development
- December 25 2014 - The 20 Largest VC-Backed Healthcare Exits of 2014 Were Valued at $13.9 Billion
- December 18 2014 - Pulmonx Names New Chief Executive Officer
- December 11 2014 - Deck The Halls With… Compensation Committees
- December 1 2014 - New Executive Vice Chancellor Hired to Lead Business Development Initiatives
- November 24 2014 - Entellus Medical, Inc. Appoints Robert White as President and Chief Operating Officer
- November 1 2014 - SOTIO, LLC Appoints Niels Borgstein as Chief Medical Officer, U.S.
- October 20 2014 - Foundation Medicine Appoints Suzanne Fleming as Vice President, Finance
- October 1 2014 - a-connect (U.S.), Inc. Appoints Mike Ferrante as Senior Client Service Partner
- August 1 2014 - TriNetX Appoints Gadi Lachman as Chief Executive Officer
- July 7 2014 - Cell Signaling Technology Appoints Dawn Mattoon as Vice President, Product Development
- July 1 2014 - Spindletop Capital Appoints Joseph Ibrahim as Managing Director
- July 1 2014 - Theravance Appoints Theodore Witek as Senior Vice President, Clinical and Medical Affairs
- June 23 2014 - GI Dynamics Appoints Randy Koester as Vice President, Quality
- May 12 2014 - Histogenics Announces Appointment of Adam Gridley to President and Chief Executive Officer
- April 7 2014 - Cell Signaling Technology Appoints Philippe Mourere as Vice President, Global Sales
- April 7 2014 - GI Dynamics Appoints Rahul Chaturvedi as Vice President, Clinical Affairs
- April 1 2014 - ConforMIS Appoints Paul Weiner as Chief Financial Officer
- February 10 2014 - Harvard University Appoints Jessica Duda as Director, Business Development
- January 14 2014 - QSpex Announces New CEO Appointment and $15M Series E Financing
- January 1 2014 - Thrasos Therapeutics Appoints Jerome Rossert as Chief Medical Officer
- December 20 2013 - ThromboGenics Appoints Dr. David Guyer to its Board of Directors
- December 18 2013 - Cognoa Appoints Brent Vaughan as Chief Executive Officer
- September 11 2013 - Theravance Appoints Brett Haumann as Vice President of Clinical Development, Respiratory
- July 1 2013 - RF Surgical Systems, Inc. Hires John T. Buhler as New CEO
- May 16 2013 - ConforMIS Appoints Senior Vice President, Operations
- May 6 2013 - Alnylam Appoints Aria Tavana, Ph.D., as Vice President of Quality Assurance
- May 1 2013 - Apple Tree Partners Appoints Diane Daych as Venture Partner of Healthcare Services
- April 30 2013 - GI Dynamics, Inc. Appoints David Maggs, M.D. as Chief Medical Officer
- April 29 2013 - Apple Tree Partners Appoints Sam Hall as Associate
- March 4 2013 - SomnoMed appoints Chief Medical Officer
- February 18 2013 - Oxford Immunotec Appoints Todd Wauters as Vice President of Sales
- February 6 2013 - Synthetic Genomics Appoints Aaron Hanson as Vice President, Operations, SGI-DNA
- January 22 2013 - Rexahn Pharmaceuticals Appoints Peter D. Suzdak as Chief Executive Officer
- January 2 2013 - Sarepta Therapeutics Appoints Shamim Ruff as Vice President, Regulatory Affairs and Quality
- December 10 2012 - Oxford Immunotec Appoints Peter Ercoli as General Manager of the Memphis Lab
